Esperite

Esperite EBITDA per Share

Delisted

The EBITDA per Share of Esperite (ESP.AS) as of Nov 16, 2026 is -0.33 EUR. In the previous year, EBITDA per Share was -0.24 EUR — a change of 35.11% (lower).

EBITDA per Share

-0.33EUR

YoY

35.11%

Last updated:

EBITDA per Share of Esperite is 2017 -0.33 EUR. EBITDA per Share of Esperite was 2016 -0.24 EUR. It decreases by 35.11% lower compared to the previous year.

The Esperite EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2014
-0.35 EUR
Jan 1, 2015
-0.48 EUR
Jan 1, 2016
-0.24 EUR
Jan 1, 2017
-0.33 EUR
The Esperite EBITDA per Share history
YEAREBITDA per ShareYoY
-0.33EUR+35.11%
-0.24EUR-49.73%
-0.48EUR+36.60%
-0.35EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Esperite Stock analysis

What does Esperite do? Esperite NV is a company based in the Netherlands that specializes in the development, production, and marketing of stem cell and cell therapies. It focuses on creating groundbreaking therapies for the treatment of serious diseases and aims to market them worldwide. Its business model includes three main segments: Life Science, Consumer Healthcare, and Branding. The Life Science segment focuses on developing stem cell and cell therapies for the treatment of diseases such as autism, cancer, and degenerative disorders. The Consumer Healthcare segment offers products related to pregnancy and fertility assistance. The Branding segment involves the development and marketing of high-quality cosmetic products. Esperite's flagship product is CryoSave, a solution for the long-term preservation of stem cells from umbilical cord blood. Esperite is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Esperite stock

EBITDA per Share of Esperite is -0.33 EUR in 2017.

EBITDA per Share of Esperite changed from -0.24 EUR to -0.33 EUR, representing a 35.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Esperite since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Esperite

All Key Metrics — Esperite